clofibric acid has been researched along with Apoplexy in 6 studies
Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Betaine is an osmolyte, supplies methyl groups, and controls plasma homocysteine." | 2.74 | Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine. ( Chambers, ST; Elmslie, JL; Fink, JN; George, PM; Lever, M; Richards, AM; Scott, RS; Slow, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakob, T | 1 |
| Nordmann, AJ | 1 |
| Schandelmaier, S | 1 |
| Ferreira-González, I | 1 |
| Briel, M | 1 |
| Lever, M | 1 |
| George, PM | 1 |
| Slow, S | 1 |
| Elmslie, JL | 1 |
| Scott, RS | 1 |
| Richards, AM | 1 |
| Fink, JN | 1 |
| Chambers, ST | 1 |
| Robins, SJ | 1 |
| Caslake, MJ | 1 |
| Packard, CJ | 1 |
| Mullard, AJ | 1 |
| Reeves, MJ | 1 |
| Jacobs, BS | 1 |
| Kothari, RU | 1 |
| Birbeck, GL | 1 |
| Maddox, K | 1 |
| Stoeckle-Roberts, S | 1 |
| Wehner, S | 1 |
| Athyros, VG | 1 |
| Papageorgiou, AA | 1 |
| Kontopoulos, AG | 1 |
3 reviews available for clofibric acid and Apoplexy
| Article | Year |
|---|---|
Fibrates for primary prevention of cardiovascular disease events.
Topics: Atorvastatin; Bezafibrate; Cardiovascular Diseases; Clofibric Acid; Fenofibrate; Gemfibrozil; Humans | 2016 |
Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?
Topics: Anticholesteremic Agents; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; | 2003 |
Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Biomarkers; Clofibric Acid; Coronary Disease; Enzyme | 2005 |
2 trials available for clofibric acid and Apoplexy
| Article | Year |
|---|---|
Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine.
Topics: Acute Coronary Syndrome; Aged; Betaine; Clofibric Acid; Cohort Studies; Diabetes Complications; Fema | 2009 |
Statin-fibrate combinations in patients with combined hyperlipedemia.
Topics: Clofibric Acid; Coronary Disease; Drug Therapy, Combination; Fibric Acids; Follow-Up Studies; Gemfib | 2001 |
1 other study available for clofibric acid and Apoplexy
| Article | Year |
|---|---|
Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients: results from a statewide stroke registry.
Topics: Aged; Anticoagulants; Cholestyramine Resin; Clofibric Acid; Female; Hospital Records; Hospitalizatio | 2006 |